Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,349
Total Claims
$870K
Drug Cost
727
Beneficiaries
$1,197
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
+26%
Opioid rate vs peers
3.2% vs 2.6% avg
-3%
Cost per patient vs peers
$1,197 vs $1,237 avg
+5%
Brand preference vs peers
9.6% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.2%
Opioid Rate
367
Opioid Claims
$4,896
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,083 claims · $670K
Generic: 10,174 claims · $196K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 198 | $199K |
| Empagliflozin | 65 | $62K |
| Semaglutide | 40 | $48K |
| Semaglutide | 24 | $28K |
| Rivaroxaban | 27 | $27K |
| Rsvpref3 Antigen/As01e/Pf | 68 | $21K |
| Insulin Glargine-Yfgn | 29 | $21K |
| Umeclidinium Brm/Vilanterol Tr | 20 | $19K |
| Dulaglutide | 13 | $17K |
| Fluticasone/Umeclidin/Vilanter | 21 | $15K |
| Dapagliflozin Propanediol | 23 | $13K |
| Atorvastatin Calcium | 707 | $11K |
| Fluticasone/Vilanterol | 20 | $10K |
| Budesonide/Formoterol Fumarate | 18 | $9,104 |
| Levothyroxine Sodium | 387 | $8,217 |
Prescribing Profile
Patient Profile
77
Avg Age
53%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About